Exhibits chromatin binding activity; phospholipase binding activity; and transcription factor binding activity. Involved in several processes, including cellular response to X-ray; cellular response to hydrogen peroxide; and histone acetylation. Localizes to cytosol; nuclear chromatin; and protein-containing complex. Biomarker of iron deficiency anemia. Orthologous to human KAT5 (lysine acetyltransferase 5); PARTICIPATES IN ataxia telangiectasia-mutated (ATM) signaling pathway; histone modification pathway; INO80 family mediated chromatin remodeling pathway; INTERACTS WITH 2,4-dinitrotoluene; bisphenol A; (-)-epigallocatechin 3-gallate (ortholog).
Estradiol inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein], Estradiol promotes the reaction [ESR1 protein binds to KAT5 protein]
[bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to KAT5 protein modified form], bisphenol A inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein]
Equol inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein], Equol inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]
Genistein inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein], Genistein inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [KAT5 protein results in increased acetylation of and results in increased degradation of SRSF2 protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in decreased expression of KAT5 protein]
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Gene-Chemical Interaction Annotations
